NextRNA Therapeutics
Committed to develop the next wave of RNA-targeted therapeutics.
Launch date
Employees
Market cap
-
Enterprise valuation
€34—51m (Dealroom.co estimates Mar 2022.)
Cambridge Massachusetts (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$9.3m | Seed | ||
* | N/A | $23.4m | Seed |
* | $9.3m | Seed | |
* | $46.8m | Series A | |
| Total Funding | €80.7m | ||
Related Content
Recent News about NextRNA Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.